Амин қышқылының қоспалары ақуызды синтездеу үшін қолданылады
Өнімнің бөлшегі
| NO | Құралдар | Cas жоқ | Негізгі сапа индикаторы | |||
| Бізіз | Макс. қоспасы | Барлығы еріткіш қалдық | Дымқыл | |||
| 1 | FMOC-β-β-Ala-Ala-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | FMOC-D-Ala-d-Ala-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | FMOC-β-Ala-d-Ala-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | FMOC-ARG (ҚКЖ) -Арг (PBF) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 |
| NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | FMOC-D-ARG (ҚКЖ) -D-arg (PBF) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | FMOC-β-Ala-D-Arg (PBF) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 |
| NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | FMOC-β-Ala-Homoarg (PBF) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | FMOC-ASN (TRT) -асы (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | FMOC-β-Ala-Asn (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | FMOC-ASP (OTBU) -Ақтар (OTBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | FMOC-β-Ala-ASP (OTBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | FMOC-CYS (TRT) -CYS (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | FMOC-β-Ala-Cys (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | FMOC-CYS (ACM) -CYS (ACM) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | FMOC-β-Ala-Cys (ACM) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | Fmoc-gln (TRT) -Gln (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | FMOC-β-Ala-Gln (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | FMOC-GLU (OTBU) -Glu (OTBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | FMOC-β-Ala-Glu (OTBU) -OH.H2O | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | FMOC-β-β-Ala-Gly-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | FMOC-оның (ТРТ) -His (TRT) -HIS (TRT) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | FMOC-β-Ala-оның (ТРТ) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | FMOC-Ile-Ile-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | FMOC-β-Ala-ane-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | FMOC-Leu-leu-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | FMOC-β-Ala-leu-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | FMOC-D-Leu-D-Leu-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | FMOC-β-Ala-D-Leu-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | FMOC-LYS (BOC) -LY (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | FMOC-β-Ala-Lys (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | FMOC-Lys (Alloc) - (Alloc) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | FMOC-β-Ala-Lys (Alloc) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | FMOC-Met-Met-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | FMOC-β-Ala-Met-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | FMOC-ORN (BOC) -н (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | FMOC-β-Ala-Orn (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | FMOC-PHE-PHE-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | FMOC-β-Ala-Phe-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | FMOC-D-PHE-D-PHE-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | FMOC-β-Ala-D-PHE-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | FMOC-Pro-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | FMOC-β-Ala-Pro-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | FMOC-Ser (TBU) -сер (TBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | FMOC-β-Ala-Ser (TBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | FMOC-Ser (TRT) -сер (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | FMOC-β-Ala-Ser (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | FMOC-TRM (TBU) -H (TBU) -Ех | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | FMOC-β-Ala-Thr (TBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | FMOC-TRP (BOC) -Трп (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | FMOC-β-ALA-TPP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | FMOC-β-Ala-D-TPP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | Fmoc-tyr (tbu) -Трир (TBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | FMOC-β-Ala-Tyr (TBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | FMOC-D-Tyr (et) -D-tyr (et) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | FMOC-β-Ala-D-Tyr (et) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | Fmoc-tyr (мен) -Тым (мен) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | FMOC-β-Ala-Tyr (мен) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | Fmoc-val-val-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | FMOC-β-β-Ala-Val-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | FMOC-D-CIT-D-Cit-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | FMOC-β-Ala-D-Cit-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | FMOC-β-Ala-Dab-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | Fmoc- (3- (2-нафтил) -D-ала) 2-оа | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | FMOC-β-Ala-3- (2-нафтил) -D-ала-о | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | FMOC- (3- (3-пиридинил) -D-ала) 2-оа) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | FMOC-β-Ala-3- (3-пиридинил) -D-ала-о | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | FMOC- (4-хлоро-д-PHE) 2-о | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | FMOC-β-Ala-4-Chloro-d-Phe-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | Fmoc- (D-4аф (TBUCBM)) 2-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | FMOC-β-Ala-D-4APH (TBUCBM) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | FMOC-aph (L-Hor) -Аф (L-Hor) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | FMOC-β-Ala-aph (L-Hor) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | FMOC-LYS (IPR, BOC) - (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | FMOC-β-Ala-Lys (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | FMOC-β-Ala-Aeaea-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | Fmoc-aib-aib-oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | FMOC-β-Ala-Aib-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | FMOC-Arg-OH | 91000-69-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H-Arg (PBF) -OH | 200115-86-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | FMOC-D-ARG-OH | 130752-32-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-ARG (PBF) -OH | 200116-81-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | FMOC-HOMOARG-OH.HCL | 208174-14-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-HOMOARG (ҚКЖ) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | FMOC-D-HOMOARG-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-гомоарг (ҚКЖ) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | Fmoc-asn-OH | 71989-16-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H-ASN (TRT) -OH | 132388-58-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | FMOC-ASP-OH | 119062-05-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-ASP (OTBU) -OH | 3057-74-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | FMOC-Cys-OH | 135248-89-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-Cys (TRT) -OH | 2799/7/7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-Cys (ACM) -OH.HCL | 28798-28-9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | Fmoc-gln-oh | 71989-20-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-gln (TRT) -OH | 102747-84-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | FMOC-Glu-OH | 121343-82-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-GLU (OTBU) -OH.H2O | 2419-56-9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | Fmoc-оның-оның | 116611-64-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-оның (TRT) -OH | 35146-32-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | Boc-оның-оның | 17791-52-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | FMOC-Lys-OH | 105047-45-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 | H-Lys (BOC) -OH | 2418-95-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | H-Lys (Alloc) -OH | 6298/3/9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | Fmoc-orn-oh.hcl | 201046-57-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 | H-orn (BOC) -OH | 13650-49-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | FMOC-Ser-OH | 73724-45-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | H-Ser (TBU) -OH | 18822-58-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 | H-Ser (TRT) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | FMOC-TH-OH.H2O | 73731-37-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-TH (TBU) -OH | 4378-13-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | FMOC-TRP-OH | 35737-15-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | H-TRP (BOC) -OH | 146645-63-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | FMOC-D-TRP-OH | 86123-11-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | HD-TRP (BOC) -OH | 201290-11-1 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 | Fmoc-tyr-OH | 92954-90-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | H-Tyr (TBU) -OH | 18822-59-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | FMOC-D-Tyr-OH | 112883-29-1 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 | HD-Tyr (et) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-tyr (мен) -ох.hcl |
| ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | FMOC-D-4APH (CBM) -OH | 324017-22-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | HD-4APH (TBUCBM) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | FMOC-Lys (IPR) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | H-Lys (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
Жөнінде
Өтемақы
Gentlex компаниясы сапалы өнімдерді ұсынады, егер клиент өнімнің барлық сапасын талап етілген мерзімде қажет болса, қажетті дәлелдемелермен көтерсе, біз төлемдер рәсімдерін тудыру үшін қажетті талдаулар мен бағалауды ұсынамыз.
Өнім
Фармацевтикалық өнімдердің қуаттылығы тонна деңгейге жетті, химиялық өнімдердің қуаттылығы 100 тоннаға + 100 тоннаға жетеді, мүмкіндіктер бүкіл әлем бойынша клиенттерге жақсы жабдықталған.
Зерттеу және дамыту
Жыл сайын ғылыми-зерттеу жұмыстары ұйымдастырылған, нысандар жиынтығы бойынша, командалар жиынтығы, әр түрлі жаңа өнімдерді дамыту жоспары белгіленеді, командадағы әрбір мүше.
